Endovascular Central Venous Stenosis Treatment Ended With Superior Vena Cava Perforation, Pericardial Tamponade, and Exitus

Siani, Andrea; Marcucci, Giustino; Accrocca, Federico; Antonelli, Roberto; Mounayergi, Federica; Rosati, Maria Sofia; Gabrielli, Roberto

doi:10.1016/j.avsg.2011.10.024

Cited by 12 publications

(10 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data were collected from the records of 70 HD patients (mean age 65, range 33-90, 32 men). Thirty-four had either an AVF (19) or an AVG (14), while 37 had a long-term CVC. Symptoms and characteristics of the treated CVS lesions are shown in Table 1.…”

Section: Populationmentioning

confidence: 99%

Stent Grafts Provided Superior Primary Patency for Central Venous Stenosis Treatment in Comparison with Angioplasty and Bare Metal Stent: A Retrospective Single Center Study on 70 Hemodialysis Patients

Quaretti

Galli

Moramarco

et al. 2016

Vasc Endovascular Surg

View full text Add to dashboard Cite

show abstract

Section: Populationmentioning

confidence: 99%

Stent Grafts Provided Superior Primary Patency for Central Venous Stenosis Treatment in Comparison with Angioplasty and Bare Metal Stent: A Retrospective Single Center Study on 70 Hemodialysis Patients

Quaretti

Galli

Moramarco

et al. 2016

Vasc Endovascular Surg

View full text Add to dashboard Cite

show abstract

“…Cardiac tamponade is the most lethal complication associated with central line catheterization, with a mortality rate between 65% and 90% [1][2][3][4][5][6][7]. In our case, central line insertion caused pericardial perforation and cardiac tamponade with the deterioration of clinical conditions.…”

Section: Discussionmentioning

confidence: 88%

A life-threatening complication of parenteral nutrition: How to prevent cardiac tamponade?

Schicchi

Piazza

Bonomo

2014

Annales de Cardiologie et d'Angéiologie

View full text Add to dashboard Cite

“…Although we believe that stent grafts are effective in occluded or stenosed cephalic arch where there is no important branch with a thin diameter, there are few advantages for stent grafts in central venous lesions. Vascular injury (cardiac tamponade) 14) and migration of stents into the right atrium or pulmonary artery 15) are serious complications during or immediately after BMS placement. In our case, a small amount of extravasation after recanalization and balloon dilatation of an occlusion was observed in a patient following stent fracture.…”

Section: Discussionmentioning

confidence: 99%

Results of Stenting for Central Venous Occlusions and Stenoses in the Hemodialysis Patients

Eguchi

Honma

2020

Annals of Vascular Diseases

View full text Add to dashboard Cite

Objectives: We aim to investigate the results of stenting for central venous occlusions and stenoses in the hemodialysis patients. Methods: Twenty-nine cases treated with endovascular recanalization with deployment of bare metal stent (BMS) for central venous occlusions (24 cases) and recurrent stenoses (5 cases) between 2014 and 2018 were retrospectively analyzed. Results of these procedures including success rate, operative time, estimated blood loss, morbidity, primary patency, assisted primary patency and freedom from targetlesion revascularization (TLR) were evaluated. Results: Nine lesions were in brachiocephalic vein (Occlusion/Stenosis: 8/1) and 20 lesions were in subclavian vein (Occlusion/Stenosis: 16/4). Procedural success was 94% (29/31 cases) and operation time/estimated blood loss was 68±39 min/28±54 g. Symptom were relieved or disappeared in all successful cases. Morbidity (extravasation of contrast medium) was 3% (1/29). During the period of observation, 1 stent fracture with occlusion and 1 stent migration to periphery were recognized. 1-year primary patency, freedom from TLR, and assisted primary patency were 40% (median patent time: 256 days), 67% (median patent time: 524 days), and 77%, respectively. Conclusion: Stenting for central venous occlusions and stenoses in the hemodialysis patients is safe and durable treatment option. However, considering its off-label use and potential hazard including vessel rupture, stent migration, and stent fracture, the indication for BMS deployment should be conservative, and interventionist should be well acquainted with prevention and measures to these complications.

show abstract

Endovascular Central Venous Stenosis Treatment Ended With Superior Vena Cava Perforation, Pericardial Tamponade, and Exitus

Cited by 12 publications

References 14 publications

Stent Grafts Provided Superior Primary Patency for Central Venous Stenosis Treatment in Comparison with Angioplasty and Bare Metal Stent: A Retrospective Single Center Study on 70 Hemodialysis Patients

Stent Grafts Provided Superior Primary Patency for Central Venous Stenosis Treatment in Comparison with Angioplasty and Bare Metal Stent: A Retrospective Single Center Study on 70 Hemodialysis Patients

A life-threatening complication of parenteral nutrition: How to prevent cardiac tamponade?

Results of Stenting for Central Venous Occlusions and Stenoses in the Hemodialysis Patients

Contact Info

Product

Resources

About